Analysts Set Integer Holdings Co. (NYSE:ITGR) Target Price at $133.86

Shares of Integer Holdings Co. (NYSE:ITGRGet Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $133.86.

Several analysts recently commented on ITGR shares. Oppenheimer started coverage on Integer in a research note on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price target on the stock. Benchmark reaffirmed a “buy” rating and issued a $130.00 price target on shares of Integer in a research note on Friday, August 2nd.

Check Out Our Latest Report on Integer

Insiders Place Their Bets

In other Integer news, Director Jean M. Hobby sold 11,960 shares of the business’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total value of $1,431,133.60. Following the transaction, the director now owns 2,280 shares of the company’s stock, valued at $272,824.80. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Integer

A number of institutional investors and hedge funds have recently bought and sold shares of ITGR. Public Employees Retirement Association of Colorado lifted its stake in shares of Integer by 3,260.1% during the fourth quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock valued at $28,281,000 after acquiring an additional 276,944 shares during the period. Norges Bank acquired a new position in shares of Integer during the fourth quarter valued at $18,697,000. Driehaus Capital Management LLC lifted its stake in shares of Integer by 62.5% during the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after acquiring an additional 135,750 shares during the period. F M Investments LLC acquired a new position in shares of Integer during the second quarter valued at $11,143,000. Finally, Point72 Europe London LLP acquired a new position in shares of Integer during the second quarter valued at $6,241,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Stock Performance

ITGR opened at $127.09 on Wednesday. The stock has a market cap of $4.26 billion, a PE ratio of 43.98, a P/E/G ratio of 1.81 and a beta of 1.09. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. Integer has a 1 year low of $69.40 and a 1 year high of $131.87. The stock’s 50 day simple moving average is $123.20 and its 200-day simple moving average is $118.83.

Integer (NYSE:ITGRGet Free Report) last released its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. The business had revenue of $436.20 million for the quarter, compared to analysts’ expectations of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. Integer’s quarterly revenue was up 9.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.14 earnings per share. Sell-side analysts forecast that Integer will post 5.31 EPS for the current year.

About Integer

(Get Free Report

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Recommended Stories

Analyst Recommendations for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.